These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10668347)

  • 21. [Surveillance of drug use--pros and cons].
    Bruhn C
    Dtsch Med Wochenschr; 2009 Aug; 134(33):p29. PubMed ID: 19705346
    [No Abstract]   [Full Text] [Related]  

  • 22. Regulators scramble to tighten loopholes after heparin debacle.
    Jia H
    Nat Biotechnol; 2008 May; 26(5):477-8. PubMed ID: 18464756
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994.
    Rawlins MD
    J R Coll Physicians Lond; 1995; 29(1):41-9. PubMed ID: 7738878
    [No Abstract]   [Full Text] [Related]  

  • 24. The drug safety system conundrum.
    Tiedt TN
    Food Drug Law J; 2007; 62(3):547-558. PubMed ID: 17915396
    [No Abstract]   [Full Text] [Related]  

  • 25. Red sky in the morning: modifying prescription drug labels as a result of postmarket surveillance.
    Jacobson JD; Feigal D
    Food Drug Law J; 2007; 62(3):529-46. PubMed ID: 17915395
    [No Abstract]   [Full Text] [Related]  

  • 26. Post-marketing studies of new insulins: sales or science?
    Gale EA
    BMJ; 2012 Jun; 344():e3974. PubMed ID: 22692652
    [No Abstract]   [Full Text] [Related]  

  • 27. The Food and Drug Administration's use of postmarketing (Phase IV) study requirements: exception to the rule?
    Steenburg C
    Food Drug Law J; 2006; 61(2):295-383. PubMed ID: 16903034
    [No Abstract]   [Full Text] [Related]  

  • 28. Postmarketing surveillance for drug safety: surely we can do better.
    Griffin MR; Stein CM; Ray WA
    Clin Pharmacol Ther; 2004 Jun; 75(6):491-4. PubMed ID: 15179403
    [No Abstract]   [Full Text] [Related]  

  • 29. Post-marketing surveillance in the UK (1984).
    Lawson DH
    Br J Clin Pharmacol; 1986; 22 Suppl 1(Suppl 1):71S-75S. PubMed ID: 3567035
    [No Abstract]   [Full Text] [Related]  

  • 30. Bad medicine.
    Sheridan C
    Nat Biotechnol; 2007 Jul; 25(7):707-9. PubMed ID: 17621284
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase IV Studies: Some Insights, Clarifications, and Issues.
    Cesana BM; Biganzoli EM
    Curr Clin Pharmacol; 2018; 13(1):14-20. PubMed ID: 29651962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Regulatory procedures of non-interventional post-authorization studies in Spain].
    Vicente Sánchez MP; González Bermejo D; Macías Saint-Gerons D; de la Fuente Honrubia C
    Farm Hosp; 2013; 37(6):530-3. PubMed ID: 24256017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Building an Evidence Base on the Place of Industry-Sponsored Programs in Drug Safety Surveillance.
    Arlett P
    Drug Saf; 2019 May; 42(5):581-582. PubMed ID: 30637598
    [No Abstract]   [Full Text] [Related]  

  • 34. Horse chestnut seed extract.
    Beck M
    Lancet; 1990 Jun; 335(8703):1467. PubMed ID: 1972241
    [No Abstract]   [Full Text] [Related]  

  • 35. Promotion of medicines.
    Massam D
    Lancet; 1989 Jun; 1(8650):1330. PubMed ID: 2566856
    [No Abstract]   [Full Text] [Related]  

  • 36. Mandatory post marketing studies.
    Somberg J
    Am J Ther; 2007; 14(4):321. PubMed ID: 17667203
    [No Abstract]   [Full Text] [Related]  

  • 37. [Medical ethics and partnership with industry].
    Autret A
    Rev Med Interne; 1994; 15(12):852-4. PubMed ID: 7863124
    [No Abstract]   [Full Text] [Related]  

  • 38. The unfinished business of U.S. drug safety regulation.
    Evans BJ; Flockhart DA
    Food Drug Law J; 2006; 61(1):45-63. PubMed ID: 16838457
    [No Abstract]   [Full Text] [Related]  

  • 39. [Drug safety and post-marketing control. Developments since the reform of the 1978 drug regulation].
    Wille H; Schönhöfer PS
    Internist (Berl); 2002 Apr; 43(4):469-70, 473-81. PubMed ID: 12053403
    [No Abstract]   [Full Text] [Related]  

  • 40. [The observational post-marketing study--an observation of use].
    Meister W
    Dtsch Med Wochenschr; 2003 Apr; 128(16):859-62. PubMed ID: 12701030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.